You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中生制药(01177.HK)旗下药品「盐酸氨基葡萄糖片」获内地部门通过一致性评价
阿思达克 01-21 12:13

中国生物制药(01177.HK)公布,附属公司江苏正大清江制药有限公司的治疗骨关节炎药物「盐酸氨基葡萄糖片」获得中国国家药品监督管理局批准通过仿制药质量和疗效一致性评价,该产品成为国内首个通过一致性评价的盐酸氨基葡萄糖制剂(750mg/片)。

氨基葡萄糖是骨关节炎对因治疗的首选药物,其主要作用机制为:提供内源性氨基葡萄糖,促进关节软骨的修复和重建;及通过抑制多种炎症介质,达到缓解和消除骨性关节炎的疼痛、肿胀等症状。氨基葡萄糖已被国内外多部临床治疗指南推荐使用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account